PMID- 19092784 OWN - NLM STAT- MEDLINE DCOM- 20090803 LR - 20150311 IS - 1740-634X (Electronic) IS - 0893-133X (Linking) VI - 34 IP - 7 DP - 2009 Jun TI - Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study. PG - 1641-8 LID - 10.1038/npp.2008.219 [doi] AB - Prospective memory refers to the realization of delayed intentions. Several studies have shown that 3,4-methylenedioxy-methamphetamine (MDMA) users perform worse on measures of prospective memory as compared to nondrug users. Interpretation of these data may be limited because of polydrug use, psychosocial stressors, and increased psychopathology that have been reported in MDMA users. This study was designed to directly assess the pharmacological effect of MDMA on prospective memory and brain activity in a double-blind, placebo-controlled, cross-over study. Twelve recreational MDMA users received MDMA 75 mg and placebo and performed an objective prospective memory task during functional imaging. During prospective memory task performance subjects were engaged in a foreground task that consisted of a simple reaction time to visual stimuli (Go trials) and a prospective task of withholding a response during trials that were part of a dynamic memory set (No go trials). Behavioral data showed that a single dose of MDMA increased prospective memory failures in the No go trials, and that number of prospective memory failures was positively correlated to MDMA concentration in plasma. Functional imaging showed that MDMA decreased BOLD activation during Go trials in the thalamus (left), putamen (left), precuneus (left), and the inferior parietal lobules (bilateral), as compared to placebo. During No go trials, MDMA reduced BOLD deactivation in the inferior parietal lobules (bilateral), as compared to placebo. It is concluded that the loss of deactivation in inferior parietal lobules may account for increments in memory failures observed during MDMA intoxication. FAU - Ramaekers, Johannes G AU - Ramaekers JG AD - Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@psychology.unimaas.nl FAU - Kuypers, Kim P C AU - Kuypers KP FAU - Wingen, Marleen AU - Wingen M FAU - Heinecke, Armin AU - Heinecke A FAU - Formisano, Elia AU - Formisano E LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20081217 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Hallucinogens) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - S88TT14065 (Oxygen) SB - IM EIN - Neuropsychopharmacology. 2009 Jun;34(7):1883-4 MH - Adult MH - Analysis of Variance MH - Brain Mapping MH - Cross-Over Studies MH - Double-Blind Method MH - Electroencephalography MH - Evoked Potentials, Visual/*drug effects MH - Female MH - Hallucinogens/blood/*toxicity MH - Humans MH - Image Processing, Computer-Assisted/methods MH - Magnetic Resonance Imaging/methods MH - Male MH - Memory Disorders/blood/*chemically induced/*pathology MH - N-Methyl-3,4-methylenedioxyamphetamine/blood/*toxicity MH - Neuropsychological Tests MH - Oxygen/blood MH - *Parietal Lobe/blood supply/drug effects/physiopathology MH - Reaction Time/drug effects MH - Young Adult EDAT- 2008/12/19 09:00 MHDA- 2009/08/04 09:00 CRDT- 2008/12/19 09:00 PHST- 2008/12/19 09:00 [entrez] PHST- 2008/12/19 09:00 [pubmed] PHST- 2009/08/04 09:00 [medline] AID - npp2008219 [pii] AID - 10.1038/npp.2008.219 [doi] PST - ppublish SO - Neuropsychopharmacology. 2009 Jun;34(7):1641-8. doi: 10.1038/npp.2008.219. Epub 2008 Dec 17.